Notably, analysis of publicly available sequencing data of 2606 breast cancer patients43–46 with cBioportal47 (http://www.cbioportal.org) also identified mutations of Arhgef11 and Plekha5 in 2.01% and 0.5% of patients, respectively. This evidence concerns the gene PLEKHA5 and breast carcinoma.